Showing: 1 - 4 of 4 RESULTS

M/C Completes Acquisition of AerioConnect, Establishing a Platform in Residential and Commercial Broadband

M/C Partners, a Boston-based Communications and IT Services focused private equity firm, announced the acquisition of AerioConnect, LLC. (“Aerio”), a leading Internet Service Provider to multi-family and commercial clients in the greater Los Angeles market. Aerio currently serves over 9,000 subscribers across 400 buildings in the greater Los Angeles market. The acquisition closed on September 30, 2020. Brady Adams, former CEO of Optic Access, has been appointed Chief Executive Officer and will be responsible for driving the company’s growth initiatives going forward.

“We are excited for the opportunity to partner with Aerio and build upon the strong foundation in residential and commercial broadband,” said Ryan Carr, Vice President at M/C Partners. “Our plan is to reinforce our commitments with our best in class, trusted partners by investing in our products and services while expanding our reach throughout the region.”

“I greatly appreciate the opportunity to join the Aerio team to

Read More

Faraday Future Completes Bridge Financing to Push Forward Production of Its All-electric FF 91 Luxury Vehicle

  • Amended Bridge Financing Includes up to $45 Million in New Senior Secured Financing

  • Birch Lake Fund Management LP, Which Led Senior Bridge Financing Facility in 2019, Returns to Support Faraday Future

 

Faraday Future (FF), a California-based global shared intelligent mobility ecosystem company, today announced that it has completed the expansion and extension of the senior bridge financing facility put in place in 2019 to support the completion and launch of its flagship FF 91 EV and continue development of the mass-market FF 81. The amended bridge facility includes new senior secured financing of up to $45 million, which matures in October 2021.

As part of the expanded and extended financing agreement, Birch Lake, a Chicago-based merchant bank, has returned to support FF as the majority purchaser of the new senior secured financing. The principals of Birch Lake and co-investor, ATW Partners, a New York-based private equity firm, bring extensive experience

Read More

Spectrum Health completes 200th diagnostic procedure for lung conditions using robotic technology

GRAND RAPIDS, MI — Spectrum Health physicians recently completed their 200th procedure using robotic technology to diagnose early-stage lung cancers, officials say.

The integrated health system’s use of a robotic bronchoscopy platform has resulted in the diagnosis of 20 percent more cases, according to an Oct. 12 news release. This improves patient outcomes by providing access to earlier treatment options with more accuracy.

Two years ago, Spectrum Health introduced Auris Health’s Monarch Platform, an innovative endoscopy tool. More recently, physicians have combined this with Phillips’ Cone Beam CT technology and augmented fluoroscopy to help diagnose with high precision.

“We are equipped with the two leading technologies in the market. By combining these two highly innovative technologies it will allow us to reach any area of concern with unprecedented accuracy,” said Dr. Gustavo Cumbo-Nacheli, director of bronchoscopy and interventional pulmonology for Spectrum Health.

“Soon we will have the ability not only

Read More

PQ Bypass Completes Enrollment in DETOUR2 Percutaneous Femoral-Popliteal Bypass Pivotal Study for Patients With Complex Peripheral Arterial Disease

FDA-designated Breakthrough Device now one step closer to PMA submission

PQ Bypass, an innovative medical device company pioneering advancements in the treatment of complex peripheral artery disease (PAD), announces enrollment of the final subject in the company’s flagship IDE, the DETOUR2 clinical trial. This important milestone occurs only a month after the Detour System entered the U.S. Food and Drug Administration’s Breakthrough Device Program.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201006005791/en/

An image of PQ Bypass’ completed Detour Procedure (Photo: Business Wire).

DETOUR2 is led by National Co-Principal Investigators Sean Lyden, MD, Professor and Chairman of the Department of Vascular Surgery at the Cleveland Clinic, and Jihad Mustapha, MD, President, CEO and Director of Endovascular Interventions at Advanced Cardiac and Vascular Centers. Both National Co-PI’s receive compensation for their duties in this role.

“The speed with which we were able to enroll DETOUR2 in 2020 speaks

Read More